medigraphic.com
SPANISH

EduMeCentro

ISSN 2077-2874 (Electronic)
EDUMECENTRO. Revista Educación Médica del Centro
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 1

<< Back Next >>

EduMeCentro 2022; 14 (1)

Relapsing-Remitting Multiple Sclerosis in the context of public health in Villa Clara

Vázquez-Gómez LA, Hidalgo MC, Broche-Pérez Y
Full text How to cite this article

Language: Spanish
References: 17
Page:
PDF size: 224.03 Kb.


Key words:

quality of life, strategies, health promotion, multiple sclerosis, recurrent-remitting multiple sclerosis, education medical.

ABSTRACT

Background: there is no nationally representative scientific information on multiple sclerosis, an important aspect not only for epidemiological control, but also updating improvement in terms of medical education and in relation to management projects, due to the high cost the treatment of the disease generates.
Objective: to characterize from the epidemiological, clinical and imaging point of view the patients diagnosed with relapsing-remitting multiple sclerosis in Villa Clara from January 2014 to December 2020.
Methods: a descriptive, cross-sectional study with a quantitative approach was carried out in patients treated at the multidisciplinary consultation for multiple sclerosis of the "Arnaldo Milián Castro" Clinical-Surgical University Hospital in Villa Clara. Theoretical, empirical and mathematical-statistical methods were used.
Results: it was observed that 57 patients were women and 66 Caucasian. The age of onset of the disease for both groups is 39.71 ± 9.86 years. The years of evolution of the disease show a mean standard deviation of 9.77 ± 5.36 years. The initial clinical manifestations were: motor, sensory and optic neuritis. Regarding the number of lesions detected by neuroimaging, it was 11.58 ± 1.59. They presented the presence of oligoclonal bands and IgG synthesis for 57.7% and 83.3% in the entire study sample, respectively.
Conclusions: the patients were characterized in a multidisciplinary way, which positions the results as novel in the national and international environment; relevant data is provided in order to increase knowledge and updated information about the disease referred to in Villa Clara.


REFERENCES

  1. Mousavizadeh A, Dastoorpoor M, Naimi E, Dohrabpour K. Time-trend analysis and developing a forecasting model for the prevalence of multiple sclerosis in Kohgiluyeh and Boyer-Ahmad Province, southwest of Iran. Public Health [Internet]. 2018 [citado 15/06/2021];154:[aprox. 9 p.]. Disponible en: http://www.sciencedirect.com/science/article/pii/S0022510X15002695

  2. Zhang G, Carrillo-Vico A, Zhang W, Gao S, Ayuso GI. Incidencia y prevalencia de la esclerosis múltiple en China y países asiáticos. Neurología [Internet]. 2020 [citado 20/03/2021]:7(22):[aprox. 14 p.]. Disponible en: http://www.sciencedirect.com/science/article/pii/S0213485320302693

  3. MS International Federation. Atlas of MS. [Internet] 2020 [citado 15/05/2021]. Disponible en: http://www.atlasofms.org/map/gñobal/epidemiology/number-of-people-with-ms

  4. Correa E, Paredes V, Martínez B. Prevalence of multiple sclerosis in Latin America and its relationship with European migration. Mult Scler J Exp Transl Clin [Internet]. 2016 [citado 19/10/2021];2:[aprox. 10 p.]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433402/pdf/10.1177_2055217316666407.pdf

  5. Gracia F, Armién B, Rivera V. Multiple sclerosis in Central American and Spanish Caribbean Region: should it be recognized as a public health problem. J Epidemiol Prev Med [Internet]. 2017 [citado 23/09/2021];3(2):[aprox. 2 p.]. Disponible en: http://focem.org/wp-content/uploads/2018/03/Multiple-Sclerosis-in-Central-American-and-Spanish-Caribbean-Region-Should-it-be-Recognized-as-a-Public-Health-Problem.pdf

  6. Estrada R. Casos presentados y discutidos en las sesiones de neuropatología. Rev Cubana Cir. 1965;4:201-24.

  7. Cabrera Gómez JA, Manero Alfert R. Algunas consideraciones sobre esclerosis múltiple en Latinoamérica. Primera estadística presentada en Cuba. Estudio comparativo. Rev Cubana Med [Internet]. 1975 [citado 19/10/2021];14(4):[aprox. 18 p.]. Disponible en: http://revmedicina.sld.cu/index.php/med/article/download/948/788

  8. Cabrera-Gómez J. Guías de práctica clínica. Esclerosis múltiple [Internet]. La Habana: Editorial Ciencias Médicas; 2009 [citado 19/10/2021]. Disponible en: http://bvs.sld.cu/libros/guia_esclerosis_multiple/esclerosis_multiple_completo.pdf

  9. Vázquez Gómez LA, Hidalgo Mesa C, Beltrán González BM, Broche-Pérez Y, Mederos-Herrera AM. Efectividad de una estrategia para el seguimiento multidisciplinario de pacientes con esclerosis múltiple. EDUMECENTRO [Internet]. 2021 [citado 04/11/2021];13(4):[aprox. 8 p.]. Disponible en: http://www.revedumecentro.sld.cu/index.php/edumc/article/view/1887/html

  10. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol [Internet]. 2018 [citado 19/10/2021];17(2):[aprox. 50 p.]. Disponible en: http://discovery.ucl.ac.uk/id/eprint/10041020/1/Barkhof_Diagnostic%20criteria_revision%201_final_10OCT2017.pdf

  11. Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet [Internet]. 2018 [citado 19/10/2021];391(10130):[aprox. 14 p.]. Disponible en: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30481-1/fulltext

  12. Bouali F, Khellaf S, Saaoui N, Meziani H, Ahmed DS. Multiple sclerosis in Algeria, a multidisciplinary management at Bejaia University Hospital Center. Int J Res Publ [Internet]. 2020 [citado 19/10/2021];54(1):[aprox. 6 p.]. Disponible en: http://ijrp.org/filePermission/fileDownlaod/4/6c7d1b5de01955ec786078560827e335/4

  13. Negrotto L, Correale J. Evolution of multiple sclerosis prevalence and phenotype in Latin America. Mult Scler Relat Disord [Internet]. 2018 [citado 19/10/2021];22:[aprox. 5 p.]. Disponible en: http://www.sciencedirect.com/science/article/pii/S2211034818301019

  14. Solomon AJ. Diagnosis, differential diagnosis, and misdiagnosis of multiple sclerosis. Contin Lifelong Learn Neurol [Internet]. 2019 [citado 19/10/2021];25(3):[aprox. 25 p.]. Disponible en: http://journals.lww.com/continuum/fulltext/2019/06000/diagnosis,_differential_diagnosis,_and.5.aspx

  15. Sand IBK, Lublin FD. Diagnosis and differential diagnosis of multiple sclerosis. Contin Lifelong Learn Neurol [Internet]. 2013 [citado 19/10/2021];19(4):[aprox. 20 p.]. Disponible en: http://journals.lww.com/continuum/fulltext/2013/08000/Diagnosis_and_Differential_Diagnosis_of_Multiple.10.aspx.

  16. Liu X, Cui Y, Han J. Estimating epidemiological data of multiple sclerosis using hospitalized data in Shandong Province, China. Orphanet J Rare Dis [Internet]. 2016 [citado 19/10/2021];11(1):[aprox. 6 p.]. Disponible en: http://link.springer.com/content/pdf/10.1186/s13023-016-0457-4.pdf.

  17. Oehninger C, Arbildi M, Alcantara JC, Gomez A. Significado de las bandas oligoclonales en la esclerosis multiple. Arch Inst Neurol [Internet]. 2011 [citado 19/10/2021];14(2):[aprox. 8 p.]. Disponible en: http://www.imbiomed.com.mx/articulo.php?id=82400




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

EduMeCentro. 2022;14